PANS: Glycemic Load, Metabolism & Obesity in Pregnancy

Sponsor
UCSF Benioff Children's Hospital Oakland (Other)
Overall Status
Completed
CT.gov ID
NCT01287299
Collaborator
University of California, San Francisco (Other), University of California, Davis (Other), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (NIH)
64
1
2
53
1.2

Study Details

Study Description

Brief Summary

The purpose of the study is to determine if a low glycemic load diet reduces the gain of body fat and insulin resistance during the last half of pregnancy in obese women.

Condition or Disease Intervention/Treatment Phase
  • Other: Low Glycemic Load diet
  • Other: Low Fat Diet
N/A

Detailed Description

Obese women will be recruited to participate in the study between 14-18 weeks gestation. After determining usual dietary intakes, visceral fat thickness, and the metabolic response to a 100g oral glucose tolerance test (OGTT) at 20 weeks gestation, 45 of the women will be randomly assigned to a low glycemic load (GL) diet and 65 women to a regular low fat diet (current standard care). They will follow their assigned diet for the last 20 weeks of gestation. A dietitian will advise the women and will monitor them throughout the study. At 28 and 34 weeks gestation, the women will come to the General Clinical Research Center (GCRC) at San Francisco General Hospital in the fasting state and the hormonal and metabolic response will be measured to another 100g oral glucose tolerance test (OGTT), and total body fat will be measured. Additional measurements include: 1) longitudinal measurements of maternal visceral fat thickness and fetal size and adiposity at 20 and 34 weeks gestation by ultrasound, 2) collection of cord blood and placental tissue, and 3) measurement of neonatal body composition by dual-energy x-ray absorptiometry and anthropometry at 2-3 weeks of age. Birth outcome data for mother and infant will be collected. To determine the metabolic response to the study diet, 25 women from each of the two diet groups will be assigned to a metabolic subsample for measuring rates of hepatic glucose production and lipolysis at 34 weeks.

Study Design

Study Type:
Interventional
Actual Enrollment :
64 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Dietary Glycemic Load & Metabolism in Obese Pregnant Women
Study Start Date :
Jul 1, 2005
Actual Primary Completion Date :
Dec 1, 2009
Actual Study Completion Date :
Dec 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Experimental: Low Glycemic Load Diet

Counseled to consume a diet with a low or higher intake of carbohydrate sources that cause rapid or significant intakes in blood glucose. The average glycemic load of the diet should be less than 55 per 1000 calories or greater than 55 per 1000 calories.

Other: Low Glycemic Load diet
Pregnant women were counseled to consume a diet with a glycemic load per 1000 kcal of less than 55.
Other Names:
  • LGL Diet
  • Experimental: Low Fat Diet

    Pregnant women were counseled to consume a diet providing less that 25% of the energy as fat.

    Other: Low Fat Diet
    Pregnant women were counseled to consume diets providing less than 25% of the energy as fat.
    Other Names:
  • LF Diet
  • Outcome Measures

    Primary Outcome Measures

    1. maternal body fat gain [20-34 weeks gestation]

      Changes in total body fat as measured by air displacement between 20 to 34 weeks gestation

    Secondary Outcome Measures

    1. Insulin Resistance [20-34 weeks gestation]

      Changes in insulin resistance measured during an oral glucose tolerance test between 20 to 34 weeks gestation.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 40 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • 35% body fat

    • 18 to 40 years of age

    • speak English or Spanish

    Exclusion Criteria:
    • have diabetes prior to pregnancy

    • diagnosed with GDM in current pregnancy

    • smoke

    • abuse alcohol or drugs

    • have a metabolic disease

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 San Francisco General Hospital San Francisco California United States 94110

    Sponsors and Collaborators

    • UCSF Benioff Children's Hospital Oakland
    • University of California, San Francisco
    • University of California, Davis
    • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    Investigators

    • Principal Investigator: Janet C King, Ph.D., UCSF Benioff Children's Hospital Oakland

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    UCSF Benioff Children's Hospital Oakland
    ClinicalTrials.gov Identifier:
    NCT01287299
    Other Study ID Numbers:
    • 2500-080
    • R01HD046741
    First Posted:
    Feb 1, 2011
    Last Update Posted:
    Nov 24, 2020
    Last Verified:
    Nov 1, 2020
    Keywords provided by UCSF Benioff Children's Hospital Oakland
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 24, 2020